Schizophrenia Research
Volume 67, Issue 1 , Pages 75-85 , 1 March 2004

The 3′ region of the DRD2 gene is involved in genetic susceptibility to schizophrenia

  • Caroline Dubertret

      Affiliations

    • Service de Psychiatrie Adulte, Faculty of Bichat-Claude Bernard, Louis Mourier Hospital (AP-HP), 178 rue des Renouillers, 92701 Colombes Cedex, France
    • INSERM U288, IFR des neurosciences (IFR 70), Faculty of Pitié-Salpêtrière Hospital, 47 Bd de l'hôpital, 75013 Paris, France
    • ,
  • Laurent Gouya

      Affiliations

    • Service de Biochimie, Fédération de Génétique Moléculaire, INSERM U409, Faculty of Bichat-Claude Bernard, Louis Mourier Hospital (AP-HP), 178 rue des Renouillers, 92701 Colombes Cedex, France
    • ,
  • Naima Hanoun

      Affiliations

    • INSERM U288, IFR des neurosciences (IFR 70), Faculty of Pitié-Salpêtrière Hospital, 47 Bd de l'hôpital, 75013 Paris, France
    • ,
  • Jean-Charles Deybach

      Affiliations

    • Service de Biochimie, Fédération de Génétique Moléculaire, INSERM U409, Faculty of Bichat-Claude Bernard, Louis Mourier Hospital (AP-HP), 178 rue des Renouillers, 92701 Colombes Cedex, France
    • ,
  • Jean Adès

      Affiliations

    • Service de Psychiatrie Adulte, Faculty of Bichat-Claude Bernard, Louis Mourier Hospital (AP-HP), 178 rue des Renouillers, 92701 Colombes Cedex, France
    • CNRS UMR 7593, Faculty of Pitié-Salpêtrière Hospital, 47 Bd de l'hôpital, 75013 Paris, France
    • ,
  • Michel Hamon

      Affiliations

    • INSERM U288, IFR des neurosciences (IFR 70), Faculty of Pitié-Salpêtrière Hospital, 47 Bd de l'hôpital, 75013 Paris, France
    • ,
  • Philip Gorwood

      Affiliations

    • Corresponding Author InformationCorresponding author. Service de Psychiatrie Adulte, Hôpital Louis Mourier, 178 rue des Renouillers, 92701 Colombes Cedex, France. Tel.: +33-1-47-60-64-16; fax: +33-1-47-60-67-40.
    • Service de Psychiatrie Adulte, Faculty of Bichat-Claude Bernard, Louis Mourier Hospital (AP-HP), 178 rue des Renouillers, 92701 Colombes Cedex, France
    • CNRS UMR 7593, Faculty of Pitié-Salpêtrière Hospital, 47 Bd de l'hôpital, 75013 Paris, France

Received 21 March 2003 ,Accepted 19 July 2003.

References 

  1. Abecasis GR, Cardon LR, Cookson WO. A general test of association for quantitative traits in nuclear families. Am. J. Hum. Genet. 2000;66:279–292
  2. Arinami Y, Itokawa M, Enguchi H, Tagaya H, Yano S, Shimizu H, et al. Association of dopamine D2 receptor molecular variant with schizophrenia. Lancet. 1994;343:703–704
  3. Arimani T, Itokawa M, Aoti J, Schibuya H, Ookubo Y, Iwawaki A, et al. Further association study on dopamine D2 receptor variant S311C in schizophrenia and affective disorders. Am. J. Med. Genet. 1996;67:133–138
  4. Arinami T, Gao M, Hamaguchi H, Toru M. A functional polymorphism in the promoter region of the dopamine D2 receptor gene is associated with schizophrenia. Hum. Mol. Genet. 1997;6:577–582
  5. Asherson P, Williams N, Roberts E, McGuffin M, Owen M. DRD2 Ser311/Cys311 polymorphism in schizophrenia. Lancet. 1994;343:1045
  6. Breen G, Brown J, Maude S, Fox H, Collier D, Li T, et al. −141 C del/ins polymorphism of the dopamine receptor 2 gene is associated with schizophrenia in a British population. Am. J. Med. Genet. 1999;88:407–410
  7. Campion D, d'Amato T, Bastard C, Laurent C, Guedj F, Jay M, et al. Genetic study of dopamine D1, D2, D3 and D4 receptors in schizophrenia. Psychiatr. Resid. 1993;51:215–230
  8. Castiglione CM, Deinard AS, Speed WC, Sirugo G, Rosenbaum HC, Zhang Y, et al. Evolution of haplotypes at the DRD2 locus. Am. J. Hum. Genet. 1995;57:1445–1456
  9. Chen CH, Chien SH, Hwu HG. No association of dopamine D2 receptor molecular variant Cys311 and schizophrenia in Chinese patients. Am. J. Med. Genet. 1996;67:483–484
  10. Comings DE, Comings BG, Muhleman D, Shahbahrami B, Tast D, Knell E, et al. The dopamine D2 receptor locus as a modifying gene in neuropsychiatric disorders. J. Am. Med. Assoc. 1991;266:1793–1800
  11. Crawford F, Hoyne J, Cai X, Osborne A, Poston D, Zaglul J, et al. Dopamine DRD2/Cys311 is not associated with chronic schizophrenia. Am. J. Med. Genet. 1996;67:483–484
  12. Daly MJ, Rioux JD, Schaffner SF, Hudson TJ, Lander ES. High-resolution haplotype structure in the human genome. Nat. Genet. 2001;29:229–232
  13. Dollfus S, Campion D, Vasse T, Preterre P, Laurent C, d'Amato T, et al. Association study between dopamine D1, D2, D3 and D4 receptor genes and schizophrenia defined by several diagnostic systems. Biol. Psychiatr. 1996;40:419–421
  14. Dubertret C, Gorwood P, Gouya L, Deybach JC, Ades J. Association and excess of transmission of a DRD2 haplotype in a sample of French schizophrenic patients. Schizophr. Res. 2001;49:203–212
  15. Fujiwara Y, Yamaguchi K, Tanaka Y, Tomita H, Shiro Y, Kashihara K, et al. Polymorphism of dopamine receptors and transporter genes in neuropsychiatric diseases. Eur. Neurol. 1997;38(Suppl. 1):6–10
  16. Gejman P, Ram A, Gelernter J, Friedman E, Cao Q, Pickar D, et al. No structural mutation in the dopamine D2 receptor gene in alcoholism or schizophrenia. Analysis using denaturing gradient electrophoresis. J. Am. Med. Assoc. 1994;271:204–208
  17. Gelernter J, Kranzler H. D2 dopamine receptor gene (DRD2) allele and haplotype frequencies in alcohol dependent and control subjects: no association with phenotype or severity of phenotype. Neuropsychopharmacology. 1999;20:640–649
  18. Gorwood P. Genetic association studies in behavioral neuroscience. In:  Cruzio W,  Gerlai R editor. Molecular Genetic Techniques for Behavioural Neuroscience. Amsterdam: Elsevier; 1999;p. 113–121
  19. Gorwood P, Leboyer M, Jay M, Payan C, Feingold J. Gender and age at onset in schizophrenia: impact of family history. Am. J. Psychiatry. 1995;152:208–212
  20. Grandy DK, Litt M, Allen L, Bunzow JR, Marchionni M, Makam H, et al. The human dopamine D2 receptor gene is located on chromosome 11 at q22–q23 and identifies a Taq1 RFLP. Am. J. Hum. Genet. 1989;45:778–785
  21. Grandy DK, Zhang Y, Civelli O. PCR detection of the TaqA RFLP at the D2 locus. Hum. Mol. Genet. 1993;2:2197
  22. Grassi E, Mortilla M, Amaducci L, Pallanti S, Pazzagli A, Galassi F, et al. No evidence of linkage between schizophrenia and D2 dopamine receptor gene locus in Italian pedigrees. Neurosci. Lett. 1996;206:196–198
  23. Hattori M, Nanko S, Dai XY, Fukuda R, Kazamatsuri H. Mismatch PCR RFLP detection of DRD2 Ser311Cys polymorphism and schizophrenia. Biochem. Biophys. Res. Commun. 1994;202:757–763
  24. Hauge XY, Grandy DK, Eubanks JH, Evans GA, Civelli O, Litt M. Detection and characterisation of additional DNA polymorphisms in the Dopamine D2 receptor gene. Genomics. 1991;10:527–530
  25. Himei A, Koh J, Sakai J, Inada Y, Akabame K, Yoneda H. The influence on the schizophrenic symptoms by the DRD2Ser/Cys311 and −141CIns/Del polymorphisms. Psychiatry Clin. Neurosci. 2002;56:97–102
  26. Hitzemann RJ. The regulation of D2 dopamine receptor expression. Mol. Psychiatry. 1998;3:198–203
  27. Hori H, Ohmori O, Shinkai T, Kojima H, Nakamura J. Association analysis between two functional dopamine D2 receptor gene polymorphisms and schizophrenia. Am. J. Med. Genet. 2001;105:176–178
  28. Inada T, Arinami T, Yagi G. Association between a polymorphism in the promoter region of the dopamine D2 receptor gene and schizophrenia in Japanese subjects: replication and evaluation for antipsychotic-related features. Int. J. Neuropsychopharmacol. 1999;2:181–186
  29. Itokawa M, Arinami T, Futamura N, Hamaguchi H, Toru M. A structural polymorphism of human dopamine D2 receptor, D2 (Ser311→Cys). Biochem. Biophys. Res. Commun. 1993;196:136
  30. Johnson GC, Esposito L, Barratt BJ, Smith AN, Heward J, Di Genova G, et al. Haplotype tagging for the identification of common disease genes. Nat. Genet. 2001;29:233–237
  31. Jönsson E, Brené S, Geijer Th, Terenius L, Tylec A, Persson ML, et al. A search for association between dopamine-related alleles. Eur. Arch. Psychiatry Clin. Neurosci. 1996;246:297–304
  32. Jonsson EG, Nothen MM, Neidt H, Forslund K, Rylander G, Mattila-Evenden M, et al. Association between a promoter polymorphism in the dopamine D2 receptor gene and schizophrenia. Schizophr. Res. 1999;40:31–36
  33. Kaneshima M, Higa T, Nakamoto H, Nagamine M. An association study between the Cys311 variant of dopamine D2 receptor gene and schizophrenia in the Okinawan population. Psychiatry Clin. Neurosci. 1997;51:379–381
  34. Kidd KK, Morar B, Castiglione CM, Zhao H, Pakstis AJ, Speed WC, et al. A global survey of haplotype frequencies and linkage disequilibrium at the DRD2 locus. Hum. Genet. 1998;103:211–227
  35. Laurent C, Bodeau-Pean S, Campion D, d'Amato T, Jay M, Dollfus S, et al. No major role for the dopamine D2 receptor Ser→Cys311 mutation in schizophrenia. Psychiatr. Genet. 1994;4:229–230
  36. Lee MS, Lee H, Kwang-Yoon S. Distribution of the TaqI polymorphism of the dopamine D2 receptor in a Korean schizophrenic population. Psychiatr. Genet. 1995;5:S59
  37. Li T, Arranz M, Aitchison KJ, Bryant C, Liu X, Kerwin RW, et al. Case–control, haplotype relative risk and transmission disequilibrium analysis of a dopamine D2 receptor functional promoter polymorphism in schizophrenia. Schizophr. Res. 1998;32:87–92
  38. Martin ER, Lai EH, Gilbert JR, Rogala AR, Afshari AJ, Riley J, et al. SNPing away at complex diseases: analysis of single-nucleotide polymorphisms around APOE in Alzheimer disease. Am. J. Hum. Genet. 2000;67:383–394
  39. May PR, Dencker SJ, Hubbard JW, Midha KK, Liberman RP. A systematic approach to treatment resistance in schizophrenic disorders. In:  Dencker S,  Kulhanel F editor. Treatment Resistance in Schizophrenia. Wiesbaden: Vieweg Verlag; 1988;p. 22–23
  40. Nanko S, Hattori M, Dai XY, Fukuda R, Kazamatsuri H. DRD2 Ser311/Cys311 polymorphism in schizophrenia. Lancet. 1994;343:1044
  41. Nöthen MM, Körne J, Lannfelt L, Sokoloff P, Schwartz JC, Lanczik M, et al. Lack of association between schizophrenia and alleles of the dopamine D1, D2, D3 and D4 receptor loci. Psychiatr. Genet. 1993;3:89–94
  42. Nöthen MM, Wildenauer D, Cichon S, Albus M, Maier W, Minges J, et al. Dopamine D2 receptor molecular variant and schizophrenia. Lancet. 1994;343:1301–1302
  43. Nurnberger JI, Blehar MC, Kaufmann CA, York-Cooler C, Simpson SG, Harkavy-Friedman J, et al. Genetics initiative diagnostic interview for genetic studies rationale, unique features, and training. Arch. Gen. Psychiatry. 1994;51:849–859
  44. Ohara K, Nakamura Y, Xie DW, Ishigaki T, Deng ZL, Tani K, et al. Polymorphisms of dopamine D2-like receptors (D2, D3 and D4) in schizophrenia. Biol. Psychiatry. 1996;40:1209–1217
  45. Ohara K, Nagai M, Tani K, Nakamura Y, Ino A, Ohara K. Functional polymorphism of Ins/Del in the dopamine D2 receptor gene promoter and schizophrenia. Psychiatry Res. 1998;81:117–123
  46. Rao PA, Pickar D, Gejman PV, Ram A, Gershon ES, Gelernter J. Allelic variation in the D4 dopamine receptor (DRD4) gene does not predict response to clozapine. Arch. Gen. Psychiatry. 1994;51:912–917
  47. Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science. 1996;273:1516–1517
  48. Sanders AR, Rincon-Limas DE, Chakraborty R, Grandchamp B, Hamilton JD, Fann WE, et al. Association between genetic variation at the porphobilinogen deaminase gene and schizophrenia. Schizophr. Res. 1993;8:211–221
  49. Sasaki T, Macciardi FM, Badri F, Verga M, Meltzer HY, Lieberman J, et al. No evidence for association of dopamine D2 receptor variant (Ser311/Cys311)with major psychosis. Am. J. Med. Genet. 1996;67:415–417
  50. Sedgwick SG, Smerdon SJ. The ankyrin repeat: a diversity of interactions on a common structural framework. Trends Biochem. Sci. 1999;24:311–316
  51. Seeman P. The absolute density of neurotransmitter receptors in the brain example for dopamine receptors. J. Pharmacol. Methods. 1987;17:347–360
  52. Serretti A, Lattuada E, Lorenzi C, Lilli R, Smeraldi E. Dopamine receptor D2 Ser/Cys 311 variant is associated with delusion and disorganization symptomatology in major psychoses. Mol. Psychiatry. 2000;5:270–274
  53. Shaikh S, Collier D, Arranz M, Ball D, Gill M, Kerwin R. DRD2 Ser311/Cys311 polymorphism in schizophrenia. Lancet. 1994;343:1045–1046
  54. Sobell J, Sigurdson DC, Heston L, Sommer S. S311C DRD2 variant: no association with schizophrenia. Lancet. 1994;344:621–622
  55. Spielman R, Ewens W. The TDT and other family-based tests for linkage disequilibrium and association. Am. J. Hum. Genet. 1996;59:983–989
  56. Spielman RS, McInnis RE, Ewens WJ. Transmission test for linkage desequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am. J. Hum. Genet. 1993;52:506–516
  57. Spurlock G, Williams J, McGuffin P, Aschauer HN, Lenzinger E, Fuchs K, et al. European Multicentre Association Study of Schizophrenia: a study of the DRD2 Ser311Cys and DRD3 Ser9Gly polymorphisms. Am. J. Med. Genet. 1998;81:24–28
  58. Stöber G, Jatzke S, Heils A, Jungkunz G, Knapp M, Mössner R, et al. Insertion/deletion variant (−141CIns/Del) in the 5′ regulatory region of the dopamine D2 receptor gene: lack of association with schizophrenia and bipolar affective disorder. J. Neural Transm. 1998;105:101–109
  59. Tallerico T, Ulpian C, Liu IS. Dopamine D2 receptor promoter polymorphism: no association with schizophrenia. Psychiatry Res. 1999;85:215–219
  60. Tanaka T, Igarashi S, Onodera O, Tanaka H, Fukushima N, Takahashi M, et al. Lack of association between dopamine D2 receptor gene Cys311 variant and schizophrenia. Am. J. Med. Genet. 1996;67:208–211
  61. Thompson EA, Deep S, Walker D, Motulsky AG. Detection of linkage disequilibrium between closely linked markers: RFLPs at the AI-CIII apolipoprotein genes. Am. J. Hum. Genet. 1988;42:113–124
  62. Verga M, Macciardi F, Pedrini S, Cohen S, Smeraldi E. No association of the Ser/Cys311 DRD2 molecular variant with schizophrenia using a case control study and the haplotype relative risk. Schizophr. Res. 1997;25(2):117–121
  63. Virgos C, Martorell L, Valero J, Figuera L, Civeira F, Joven J, et al. Association study of schizophrenia with polymorphisms at six candidate genes. Schizophr. Res. 2001;49:65–71
  64. Zhao H, Zhang S, Merikangas KR, Trixler M, Wildenauer DB, Sun F, et al. Transmission/disequilibrium tests using multiple tightly linked markers. Am. J. Hum. Genet. 2000;67:936–946

PII: S0920-9964(03)00220-2

doi: 10.1016/S0920-9964(03)00220-2

Schizophrenia Research
Volume 67, Issue 1 , Pages 75-85 , 1 March 2004

Article Tools

* Image Usage & Resolution